C. Kang

Regional variation in states’ naloxone accessibility laws in association with opioid overdose death rates-Observational study (STROBE compliant)

Jay J. Shen, Seong-min Park, Hee-Taik Kang, 2020, Medicine.

Association of HLA class I homozygosity with unfavorable clinical outcomes in patients with non-small cell lung cancer treated with PD-1/PD-L1 inhibitor as first-line therapy

Y. Kim, Y. Chae, H. Choi, 2021, medRxiv.

Association of HLA class I homozygosity with unfavorable clinical outcomes in patients with non-small cell lung cancer treated with chemo-immunotherapy or immunotherapy as first-line therapy

Yeseul Kim, Y. Chae, Jonghanne Park, 2021, Heliyon.

Blood transfusions may adversely affect survival outcomes of patients with lung cancer: a systematic review and meta-analysis

A. Bharat, G. Cho, Y. Chae, 2021, Translational Lung Cancer Research.

Artificial Intelligence-based Radiomics in the Era of Immuno-oncology

M. Abazeed, Yeseul Kim, Y. Chae, 2022, The oncologist.

Overcoming acquired resistance to PD-1 inhibitor with the addition of metformin in small cell lung cancer (SCLC)

J. Y. Lee, Yeseul Kim, Y. Chae, 2020, Cancer Immunology, Immunotherapy.

A rare case of left dominant pulmonary edema in acute mitral regurgitation

C. Kang, J. Tottleben, V. R. Pinzon, 2022, Respiratory medicine case reports.